SearchSearch results for: “”

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe advises Investcorp, a global provider and manager of alternative investment products, on its acquisition of SPGPrints Group from funds managed by Bencis Capital Partners.

Stibbe advised a French public infrastructure investment fund on the acquisition of an interest in a German wind farm project.

Advising parties in relation to damages occurred or to occur in relation to gas mining activities in the northern part of The Netherlands.

Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.

Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion.

Stibbe advised a US asset manager on securing the acquisition of a real estate portfolio in France via a Luxembourg, non-regulated fund platform.

Stibbe assisted the Belgian Buildings Agency in its claim for time extension and additional payment and in a litigation with the contractor concerning the ‘Residence Palace Building’, a new landmark in Brussels that will be the seat of the EU Council.

Stibbe represented a global lifts manufacturer in several antitrust damage proceedings in Belgium brought by several entities, including the European Commission, following the European Commission's finding of an antitrust infringement in the elevator and

Stibbe advises The Blackstone Group.